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Background: An automated dose dispensing (ADD) service has been implemented in primary healthcare in some
European countries. In this service, regularly used medicines are machine-packed into unit-dose bags for each time
of administration. The aim of this study is to review the evidence for ADD’s influence on the appropriateness of
medication use, medication safety, and costs in primary healthcare.
Methods: A literature search was performed in April 2012 in the most relevant databases (n = 10), including the
Medline, Embase, and Cochrane Library. The reference lists of the studies selected were manually searched. A study
was included in the review if the study was conducted in primary healthcare or nursing home settings and
medicines were dispensed in unit-dose bags.
Results: Out of 328 abstracts, seven studies met the inclusion and reporting quality criteria, but none applied a
randomized controlled study design. Of the four controlled studies, one was a national register-based study. It showed
that the patient group in the ADD scheme more often used three or more psychotropic drugs and anticholinergics
than patients using the standard dispensing procedure, while women in the ADD group used less long-acting
benzodiazepines and both genders had fewer drug-drug interactions. In another, regional controlled study, the ADD
group consisted of patients with higher risk of inappropriate drug use, according to all indicators applied. The third
controlled study indicated that ADD user drug treatments were more likely to remain unchanged than in patients
using a standard dispensing procedure. A controlled study from Norway showed that ADD reduced discrepancies in
the documentation of patient medication records. Costs were not investigated in any of the studies.
Conclusions: A very limited number of controlled studies have explored ADD in primary healthcare. Consequently, the
evidence for ADD’s influence on appropriateness and safety of medication use is limited and lacking in information on
costs. The findings of this review suggest that patients using the ADD have more inappropriate drugs in their regimens,
and that ADD may improve medication safety in terms of reducing the discrepancies in medication records. Further
evidence is needed to draw sound conclusions on ADD’s outcomes.
Keywords: Automated dose dispensing, Medication safety, Primary healthcare, Patient safety, Medication useBackground
Medication errors are preventable events that may cause
or lead to inappropriate medication use [1]. They are
common and can occur at any stage of the medication
process in inpatient and outpatient care [2,3]. Therefore,
it is important to identify the weak stages of the medica-
tion process and develop preventive mechanisms to* Correspondence: juha.sinnemaki@helsinki.fi
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distribution, and reproduction in any mediumavoid the errors. Automated dose dispensing (ADD) may
serve to enhance medication safety, particularly among
elderly outpatients with multiple medications.
ADD is a service in which regularly used medicines
are machine-packed into unit-dose bags for each time of
administration [4]. ADD is used in primary healthcare in
Sweden, Denmark, Norway, and Finland, Sweden having
the highest volume with 185,000 patients using ADD in
2009 [4-8]. Community pharmacies in Denmark have
been obliged to provide ADD since 2003 [6]. The medi-
cine agencies of Sweden and Norway established guidelines
on dose dispensing in 2010 and 2000, respectively [9,10].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Search strategy for the medline
Ovid MEDLINE(R)
1 automated medication dispens*.ti,ab. (20)
2 automated medication distribut*.ti,ab. (6)
3 automated drug distribut*.ti,ab. (5)
4 automated drug dispens*.ti,ab. (14)
5 automated dose-dispens*.ti,ab. (3)
6 automated dose distribut*.ti,ab. (0)
7 automated dispensing system*.ti,ab. (29)
8 multidose drug dispens*.ti,ab. (0)
9 multi-dose drug dispens*.ti,ab. (2)
10 multidose drug distribut*.ti,ab. (1)
11 multi-dose drug distribut*.ti,ab. (1)
12 unit-dose dispens*.ti,ab. (45)
13 unit-dose distribut*.ti,ab. (33)
14 (automat* adj2 (dispens* or distribut*) adj2 (device* or system* or
scheme*)).ti,ab. (96)
15 (automat* adj2 dose dispens*).ti,ab. (7)
16 (automat* adj2 dose distribut*).ti,ab. (10)
17 ((multidose or multi-dose) adj2 dispens*).ti,ab. (8)
18 ((multidose or multi-dose) adj2 distribut*).ti,ab. (5)
19 (unit-dose adj2 (dispens* or distribut*)).ti,ab. (218)
20 or/1-19 (350)
21 (news or letter or comment or editorial or interview or historical
article).pt. (1438428)
22 20 not 21 (338)
23 limit 22 to yr=”1995-current
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implemented through legislation in 2011 [11]. The ser-
vice is delivered nationally through community pharma-
cies that buy the dose bags from two providers [12].
Currently, about 300 out of a total of 600 community
pharmacies provide the ADD service. The number of
patients using the scheme is about 20,000.
The Ministry of Social Affairs and Health has recom-
mended the ADD service for elderly primary healthcare
patients to ensure safe medication [13]. Since 2006, the
ADD service has been partly reimbursed by the public
insurance that covers the entire population [14]. The
service is only reimbursed for aged patients (≥75 years)
using six or more reimbursable prescription medicines
that are suitable for ADD.
The ADD service is expected to enhance patient safety,
decrease medication costs, and save nurses working time
in the primary healthcare [4]. No published systematic
reviews have been conducted to evaluate the outcomes of
the ADD service. The aim of this study was to review the
evidence for influence of ADD on the appropriateness of




A literature search was performed in April 2012 on the
following databases: Medline, Medline in-process, and
other non-indexed citations, Cochrane database of sys-
tematic reviews, Cochrane central register of controlled
trials, Cinahl, Journals@Ovid, NHS Economic evaluation
database (EED), Health technology assessment database
(HTA), Database of abstracts of reviews of effectiveness
(DARE), and Embase. Key search terms included: auto-
mated medication/drug dispensing, automated medication/
drug distribution, automated dose dispensing/distribution,
automated dispensing system, multidose drug dispensing/
distribution, and unit-dose dispensing/distribution. Reports
and studies published from early 1995 to April 2012 were
included in the literature search. The search was not li-
mited by language. An example of the search strategy is in
Table 1. The reference lists of the studies selected were
manually searched. Finnish literature databases were also
searched, using a strategy similar strategy to that of the
international databases.
Inclusion and exclusion criteria
A study was included in the review if it was conducted in
primary healthcare or nursing home settings and the
medicines were dispensed for patients in unit-dose bags.
Studies performed in hospital settings were excluded, as
well as those with manually distributed medicines to unit-
dose cups or any similar procedures. Control groups were
not required, because there were few studies performedon ADD in primary healthcare. Qualitative studies and
case reports were excluded. Studies applying outcome
measures that were associated with the appropriateness of
medication use or medication safety were included. Stud-
ies regarding costs or any other type of economic evalu-
ation of ADD were also included. In short, the following
PICO was applied in this study: Patients (patients from
primary healthcare or nursing homes), Intervention
(ADD), Comparison (usual care/not ADD; not required),
and Outcomes (appropriateness of medication use, medi-
cation safety, and costs).
Data extraction
Two reviewers (JS, SS) independently selected studies,
based on abstracts according to inclusion and exclusion
criteria. Disagreements were resolved through discussion
and consensus. Study characteristics, aim of the study,
description of ADD, study population and data collec-
tion, outcome measures, and main results categorized to
appropriateness of medication use, medication safety,
and costs were extracted by one of the authors (JS) to a
table (Table 2). Table 2 was carefully reviewed by the
other authors.



















To compare changes in
drug treatments within
and outside ADD
Level 2 154 community-dwelling or
nursing home residents
≥65 years of age (patients
using ADD n = 107, not using
ADD n = 47). Data on drug
treatments were extracted
from the medical records
(t = 0 months) and from the
SPDR (t = 6 months). A multi-
level analysis was performed,
with drugs at the first level










The risk of medication to be
classified as unchanged was
higher among ADD users
(OR 1.66, 95% CI 1.20-2.31,
adjusted for age, sex,
cognition, year of data






ADD and quality of
drug treatment
Level 3 All community-dwelling or
nursing home residents from
Västra Götaland ≥65 years of
age in late 2007 and having
≥2 health care visits and ≥2
diagnosis in 2005–2007. Study
group: ADD users (n = 4927).
Control group: patients not
using ADD (n = 19 219). Data
were collected from the SPDR
in 2007 linked with register










1. Use of ≥10 drugs ADD users had a higher
prevalence of all indicators of
potential IDU (5.9-55.1%) than
the control population
(2.6-4.9%) (P <0.0001). After
adjustment for age, sex,
burden of disease, and
residence, risk of all indicators
of potential IDU were higher
among ADD users (ORs 1.36-
5.48; 95% CI 1.18-6.30).










Impact of ADD on
inconsistencies in
medication records
between GPs and home
care services
Level 3 A convenience sample of 59
patients. Medication records
were collected 0.5 years before






the GPs and at the
home care services
Medication safety
ADD did not change the
number of medication records
with discrepancies (before 47
and after 45 out of 59,
P = 0.774, n.s.), but reduced
total number of discrepancies







Whether the use of
ADD is associated with
potential IDU
Level 2 All Swedes ≥75 years of age
who were registered in SPDR.
Study group: ADD users
(n = 122 413). Control group:
patients not using ADD
(n = 608, 692). Data were






ADD users had a higher
prevalence of all indicators of











After adjustment for age and
number of dispensed drugs,
risk of using any IDU,
anticholinergic drugs and ≥3
psychotropic drugs were
higher among ADD users




women and potentially serious
DDIs among women and men
(ORs 0.69-0.80; 95%
CI 0.66-0.83).
3. use of ≥3
psychotropic drugs
4. potential DDIs
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Extent and quality of
drug prescribing in
younger elderly







All residents of nursing homes
and dementia special care
units ≥65 years of age
(n = 3705) from the County of
Jönköping. Data on prescribed










1. Use of long-acting
benzodiazepines
Influence of ADD on potential
IDU not studied. Potential IDU
prevalences ranged from 7.6%
to 41.2%. Prevalences of
potential IDU were mainly
higher among younger
(65–79 years) than older

















factors for these errors
in nursing homes using
ADD
Level 2 In all, 2025 administrations to
127 residents of three nursing






Administration error rate for all
administered medications
observed (via ADD and
without ADD) was 21.2%
(n = 428 errors). Most common
error type was wrong
administration technique
(n = 312). The risk for
administration errors was
higher when medicine was








Quality of drug therapy
among nursing home
residents using ADD
Level 1 All nursing home residents
≥65 years of age (n = 7904)
from Gothenburg area. Data
were collected from the









1. use of long-acting
benzodiazepines
Influence of ADD on potential
IDU not studied. Potential IDU
prevalences ranged from
12.1% to 45.2%. The
proportion of potential IDU
was higher among
65–79 year-old residents than





4. Use of ≥3
psychotropic drugs
5. Potential DDIs
ADD, Automated dose dispensing; DDI, Drug-drug interaction; GP, General practitioner; IDU, Inappropriate drug use; n.s., Not significant; SPDR, Swedish Prescribed
Drug Register.
aLevels of description: Level 1: Drugs are machine-packed into unit-dose bags. One unit-dose bag contains all the tablets that are administered to a patient at
the same time; Level 2: In addition to level 1, each bag has a label with the following information: patient’s name, the name(s) of the medication(s), and the date
and time of administration; Level 3: In addition to levels 1 and 2, a medication record was set up.
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The quality of reporting of the studies selected was assessed
using the STROBE checklist (Additional file 1) [22]. The
proportion of adequately reported items (yes) to applicable
questions was counted. The quality was considered good
when the proportion of adequately reported items (yes) to
applicable questions was higher than 80% and acceptable
when the proportion was >60% but <80%.
Results
Included studies
Seven studies met the inclusion criteria (Figure 1) [15-21].
In all, 328 citations were found in the literature search. A
total of 59 of the citations were retrieved as full texts and53 of these were excluded. One of those included was
found in the reference list of the included study. No rele-
vant studies were found in the Finnish literature.
The data extraction of the studies selected is presented
in Table 2. Six out of seven studies were conducted in
the Nordic countries, [15-19,21] and one was from the
Netherlands [20]. Five studies were register-based stu-
dies [15,16,18,19,21]. Other studies applied before-after,
[17] and observational study designs [20]. Four of the
studies had control group [15-18]. Two of the register-
based studies were descriptive, cross-sectional studies
without any follow-up of the ADD intervention [19,21].
Seven of the studies included a description of ADD
[15-18,20,21], which varied between the studies. The
Search results:
328 citations
Excluded by abstracts: 268 citations
Full assessment:
59 citations
Excluded by full texts: 53 studies
Reasons:
Study was performed in a hospital 
setting or dose dispensing did not 
meet the inclusion criteria n=26
Article was not a study report n=18
Study design: case-report or 
qualitative study n=4






Figure 1 Flow chart of the study selection process.
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four of the studies [16-18,20] and acceptable in three
(Additional file 1) [15,19,21].
Appropriateness of medication use
Appropriateness of medication use was investigated in five
of the studies [15,16,18,19,21]. In four of these the focus
was on potential inappropriate drug use [16,18,19,21], two
of which were controlled. All of the studies were con-
ducted in Sweden. Inappropriate drug use was measured,
using the following quality indicators: use of long-acting
benzodiazepines, use of anticholinergic drugs, use of three
or more psychotropic drugs, drug duplications, use of 10
or more drugs, and potential drug-drug interactions [23].
Controlled studies (n = 3)
In the controlled studies, patients using the ADD scheme
were those with higher prevalences of potential inappro-
priate drug use according to all quality indicators, than
those using a standard dispensing procedure (5.9-55.1%
vs. 2.4-4.9%) [16,18]. After controlling the results of the
representative population-based register study for age and
number of drugs dispensed, patients using the ADD
scheme had a higher risk using anticholinergic and three
or more psychotropic drugs (ORs 1.43-4.93; 95% CI
1.40-5.17) [18]. The contrasting association prevailed for
long-acting benzodiazepine use among women and drug-
drug interactions among women and men (ORs 0.69-0.80;
95% CI 0.66-0.83). When the results of the regional regis-
ter study were adjusted for age, sex, burden of disease, and
residence, the risk for inappropriate drug use was higheramong the ADD users than in patients using a standard
dispensing procedure, according to all indicators applied
(ORs 1.36-5.48; 95% CI 1.18-6.30) [16]. In this study, more
comprehensive controlling of the confounding factors was
applied than in the population-based register study [18].
Drug treatment changes were studied in Sweden [15].
Drug treatment of the ADD users was more likely to re-
main unchanged than in patients using a standard dis-
pensing procedure (OR 1.66, 95% CI 1.20-2.31, adjusted
for age, sex, cognition, year of data collection, and sub-
group of drug).
Uncontrolled studies (n = 2)
The prevalences of potential inappropriate drug use were
higher among 65-79-year-old ADD users than older users
(≥80 years) in the uncontrolled regional register studies
(n = 2) [19,21].
Medication safety
The influence of ADD on medication safety was investi-
gated in two of the studies, of which one was controlled
[17] and the other uncontrolled [20].
Controlled study (n = 1)
The controlled study conducted in Norway explored the
impact of ADD on inconsistencies in medication records
between general practitioners and home care services [17].
It showed that the ADD implementation reduced discrep-
ancies in medication records by 34% (P < 0.001) between
the general practitioners and home care services.
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The uncontrolled study investigated the frequency of
medication administration errors and potential risk fac-
tors for these errors in nursing homes using ADD [20].
The study indicated that the risk of administration
errors was higher when the medication was not supplied
by ADD (OR 2.92; 95% CI 2.04-4.18).
Costs
Costs were not investigated nor was economic evaluation
performed in any of the studies.
Discussion
Few studies have investigated the outcomes of the ADD
service in primary healthcare, and the scientific evidence
is too limited to draw any explicit conclusions on its
effectiveness in improving the quality of pharmacother-
apy. The findings of the controlled studies reviewed sug-
gest that patients using the ADD service were those
having more inappropriate drug use than the patients
using the standard dispensing procedure. The findings
also suggest that the ADD service may improve medica-
tion safety in terms of reducing discrepancies in the
documentation of patient medication records in primary
healthcare. At the same time, ADD may pose a risk of
continuing the drug treatment unchanged for an un-
necessarily long period if the medication is not regularly
reviewed.
Two of the four controlled studies reviewed indicate
that patients using the ADD scheme include those with
more complicated drug regimens and high-risk medica-
tions, such as anticholinergics and psychotropics [16,18].
This finding is in line with the idea of ADD as a preven-
tive intervention targeted to patients with a higher risk
of drug-related problems, medication errors, or inappro-
priate drug use. There is recent evidence that ADD
patients’ quality of pharmacotherapy may be improved
by regular medication reviews integrated with ADD [24].
Medication reviews may also reduce the risk of un-
changed medications for unnecessarily long periods,
once a patient is enrolled in the ADD procedure [15].
These aspects support the idea that medication review
should be integrated as a part of the ADD procedure to
identify and solve inappropriate drug use. However, none
of the seven studies included in the review indicated
whether the standard ADD procedure applied involved a
medication review to assure appropriateness of the dose-
dispensed medications. In Finland, the Association of
Finnish Pharmacies has recommended that each patient’s
medications should be reviewed in the community phar-
macy before they are enrolled in the ADD service [4]. The
Ministry of Social Affairs and Health has recommended
that medications for the elderly should be reviewed at
least once per year [13]. Further research should befocused on this area to optimize the ADD procedure from
the inappropriate drug use perspective.
The studies included applied quite a limited range of
outcome measures. Outcome measures associated with
costs were missing from all the studies. In future studies,
it would be essential to estimate costs and benefits
from different stakeholder points of view. These stake-
holders include healthcare decision-makers and provi-
ders, patients and relatives, community pharmacies, and
public insurance. When ADD systems are implemented
in primary healthcare, it is also important to identify
what kind of changes these systems make in nurses’ du-
ties and allocation of working time, since they are mainly
responsible for the distribution and administration of
medicines to patients in home care services and nursing
homes. Evidence from hospital settings indicates that
changes in the work process can lead to new kinds of
medication errors [25,26]. For example, nurses check the
medicines less carefully because they rely on the auto-
mation. Therefore, it is important to involve parties of
the medication process in the ADD implementation
process. The work processes after ADD implementation
of ADD should be assessed to ensure their safety in pri-
mary healthcare.
Even though evidence for the benefits of the ADD ser-
vice in primary healthcare is limited, the service is offi-
cially implemented and widely used in the Nordic
countries. This may be due to the urgent need for fin-
ding strategies and tools to ensure the safe use of medi-
cines in a rapidly growing elderly population. Further
research applying relevant study designs, methods, and
outcome measures is needed to provide evidence for
ADD service benefits in terms of medication safety,
appropriateness of medication use, and costs.
Strengths and limitations of the systematic review
So far, this is the first systematic review of ADD in pri-
mary healthcare. The literature search was performed in
various databases with several keywords. Two research-
ers selected the studies independently. The Finnish lit-
erature was also searched.
The study has some limitations. The major limitation
is the very limited published evidence for ADD in pri-
mary healthcare [27]. The seven studies that passed the
inclusion criteria and reporting assessment had weak-
nesses in the study designs, sampling, and research
methods, hindering the generalization of the findings.
Three out of seven studies were uncontrolled [19-21],
even though controlled studies provide more adequate
evidence for the outcome of the intervention [28]. Only
one of the studies was population-based [18]. Further-
more, the ADD service procedure varied between stu-
dies. The literature search was restricted to starting from
the year 1995. However, in a narrative search done
Sinnemäki et al. Systematic Reviews 2013, 2:1 Page 7 of 7
http://www.systematicreviewsjournal.com/content/2/1/1before the systematic search, studies from the late 1980s
and early 1990s were not found, because the earliest
time the ADD service was launched in primary health-
care was in the late 1980s in Sweden [5].
Conclusions
A very limited number of controlled studies have explored
ADD in primary healthcare. Consequently, the evidence
for ADD’s influence on appropriateness and safety of
medication use is limited, and lacking in information on
costs. The findings of this review suggest that patients
using the ADD have more inappropriate drugs in their
regimens, and that ADD may improve medication safety
in terms of reducing the discrepancies in medication
records. Further evidence is needed to draw sound conclu-
sions on ADD’s outcomes.
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